Explore the latest in influenza, including recent advances in epidemiology of the infection, vaccine development, and diagnosis and treatment.
This decision analytical model estimates whether increases in COVID-19 bivalent booster vaccination uptake in the eligible US population would be associated with reduced hospitalizations and school absenteeism among children.
This study uses data from the US Department of Veterans Affairs to assess whether SARS-CoV-2 remains associated with higher risk of death compared with seasonal influenza in fall-winter 2022-2023.
This randomized clinical trial investigates the effectiveness of a parent short message service (SMS) reminder nudge to improve influenza vaccination uptake in children and adolescents with special risk medical conditions.
This Medical News article discusses recent reports of mammal-to-mammal transmission of highly pathogenic avian influenza H5N1.
This cohort study compares in-hospital outcomes among patients hospitalized with the SARS-CoV-2 Omicron variant vs those hospitalized with influenza A or B in Switzerland.
This prospective study compares the risk of transmission of influenza virus infection among household contacts of patients with influenza during the 2021-2022 influenza season vs before the COVID-19 pandemic influenza seasons in the US.
This Medical News article discusses an out-of-season increase in respiratory syncytial virus, influenza, and other respiratory infections that is severely straining the pediatric health care system.
This survey study assesses how COVID-19 vaccination differs across historical influenza vaccination patterns and whether influenza vaccination changed during the COVID-19 pandemic.
This cohort study examines a large multicenter data set over 13 influenza seasons to determine whether early use of oseltamivir is associated with improved outcomes in children hospitalized with influenza.
This Medical News feature discusses the challenges of predicting how severe flu season might be.
This cohort study assesses whether influenza vaccination is associated with SARS-CoV-2 infection and related outcomes such as hospitalization or mortality in individuals aged 66 years or older.
Customize your JAMA Network experience by selecting one or more topics from the list below.